← Evidence map

TrialInvestigational new drugs2004

Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study.

Susan G Urba et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

this papertrialcites it

Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study. | OpenQuestion